nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—Dactinomycin—testicular cancer	0.111	0.223	CbGbCtD
Acebutolol—ABCB1—Vinblastine—testicular cancer	0.0693	0.14	CbGbCtD
Acebutolol—CYP2D6—Vinblastine—testicular cancer	0.0653	0.132	CbGbCtD
Acebutolol—ABCB1—Cisplatin—testicular cancer	0.0635	0.128	CbGbCtD
Acebutolol—ABCB1—Etoposide—testicular cancer	0.0624	0.126	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—testicular cancer	0.0426	0.086	CbGbCtD
Acebutolol—ABCB1—Methotrexate—testicular cancer	0.0412	0.0833	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—testicular cancer	0.0401	0.081	CbGbCtD
Acebutolol—Asthenia—Dactinomycin—testicular cancer	0.000823	0.00163	CcSEcCtD
Acebutolol—Dysuria—Methotrexate—testicular cancer	0.000818	0.00162	CcSEcCtD
Acebutolol—Paraesthesia—Cisplatin—testicular cancer	0.000814	0.00161	CcSEcCtD
Acebutolol—Dyspnoea—Cisplatin—testicular cancer	0.000808	0.0016	CcSEcCtD
Acebutolol—Skin disorder—Etoposide—testicular cancer	0.000807	0.0016	CcSEcCtD
Acebutolol—Erectile dysfunction—Methotrexate—testicular cancer	0.000806	0.0016	CcSEcCtD
Acebutolol—Hyperhidrosis—Etoposide—testicular cancer	0.000803	0.00159	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—testicular cancer	0.0008	0.00159	CcSEcCtD
Acebutolol—Anorexia—Etoposide—testicular cancer	0.000792	0.00157	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000789	0.00156	CcSEcCtD
Acebutolol—Decreased appetite—Cisplatin—testicular cancer	0.000788	0.00156	CcSEcCtD
Acebutolol—Diarrhoea—Dactinomycin—testicular cancer	0.000785	0.00155	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—testicular cancer	0.000784	0.00155	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000783	0.00155	CcSEcCtD
Acebutolol—Vomiting—Bleomycin—testicular cancer	0.000782	0.00155	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—testicular cancer	0.00078	0.00154	CcSEcCtD
Acebutolol—Depression—Methotrexate—testicular cancer	0.000778	0.00154	CcSEcCtD
Acebutolol—Hypotension—Etoposide—testicular cancer	0.000776	0.00154	CcSEcCtD
Acebutolol—Rash—Bleomycin—testicular cancer	0.000776	0.00154	CcSEcCtD
Acebutolol—Pain—Cisplatin—testicular cancer	0.000775	0.00154	CcSEcCtD
Acebutolol—Dermatitis—Bleomycin—testicular cancer	0.000775	0.00153	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—testicular cancer	0.000765	0.00152	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—testicular cancer	0.000758	0.0015	CcSEcCtD
Acebutolol—Asthenia—Ifosfamide—testicular cancer	0.000754	0.00149	CcSEcCtD
Acebutolol—Sweating—Methotrexate—testicular cancer	0.000748	0.00148	CcSEcCtD
Acebutolol—Feeling abnormal—Cisplatin—testicular cancer	0.000747	0.00148	CcSEcCtD
Acebutolol—Paraesthesia—Etoposide—testicular cancer	0.000746	0.00148	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—testicular cancer	0.000745	0.00148	CcSEcCtD
Acebutolol—Pruritus—Ifosfamide—testicular cancer	0.000744	0.00147	CcSEcCtD
Acebutolol—Dyspnoea—Etoposide—testicular cancer	0.00074	0.00147	CcSEcCtD
Acebutolol—Somnolence—Etoposide—testicular cancer	0.000738	0.00146	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—testicular cancer	0.000734	0.00145	CcSEcCtD
Acebutolol—Nausea—Bleomycin—testicular cancer	0.000731	0.00145	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—testicular cancer	0.00073	0.00145	CcSEcCtD
Acebutolol—Vomiting—Dactinomycin—testicular cancer	0.00073	0.00144	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—testicular cancer	0.000728	0.00144	CcSEcCtD
Acebutolol—Rash—Dactinomycin—testicular cancer	0.000723	0.00143	CcSEcCtD
Acebutolol—Decreased appetite—Etoposide—testicular cancer	0.000722	0.00143	CcSEcCtD
Acebutolol—Diarrhoea—Ifosfamide—testicular cancer	0.000719	0.00142	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000717	0.00142	CcSEcCtD
Acebutolol—Body temperature increased—Cisplatin—testicular cancer	0.000717	0.00142	CcSEcCtD
Acebutolol—Fatigue—Etoposide—testicular cancer	0.000716	0.00142	CcSEcCtD
Acebutolol—Constipation—Etoposide—testicular cancer	0.00071	0.00141	CcSEcCtD
Acebutolol—Pain—Etoposide—testicular cancer	0.00071	0.00141	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—testicular cancer	0.000709	0.0014	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—testicular cancer	0.000708	0.0014	CcSEcCtD
Acebutolol—Sweating—Epirubicin—testicular cancer	0.0007	0.00139	CcSEcCtD
Acebutolol—Dizziness—Ifosfamide—testicular cancer	0.000695	0.00138	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—testicular cancer	0.000695	0.00138	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—testicular cancer	0.000689	0.00137	CcSEcCtD
Acebutolol—Feeling abnormal—Etoposide—testicular cancer	0.000684	0.00136	CcSEcCtD
Acebutolol—Nausea—Dactinomycin—testicular cancer	0.000682	0.00135	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—testicular cancer	0.000681	0.00135	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—testicular cancer	0.000679	0.00135	CcSEcCtD
Acebutolol—Gastrointestinal pain—Etoposide—testicular cancer	0.000679	0.00134	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—testicular cancer	0.000675	0.00134	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—testicular cancer	0.000675	0.00134	CcSEcCtD
Acebutolol—Vomiting—Ifosfamide—testicular cancer	0.000668	0.00132	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—testicular cancer	0.000667	0.00132	CcSEcCtD
Acebutolol—Rash—Ifosfamide—testicular cancer	0.000663	0.00131	CcSEcCtD
Acebutolol—Dermatitis—Ifosfamide—testicular cancer	0.000662	0.00131	CcSEcCtD
Acebutolol—Urticaria—Etoposide—testicular cancer	0.00066	0.00131	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—testicular cancer	0.000657	0.0013	CcSEcCtD
Acebutolol—Abdominal pain—Etoposide—testicular cancer	0.000656	0.0013	CcSEcCtD
Acebutolol—Body temperature increased—Etoposide—testicular cancer	0.000656	0.0013	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—testicular cancer	0.000656	0.0013	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—testicular cancer	0.000653	0.00129	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—testicular cancer	0.000652	0.00129	CcSEcCtD
Acebutolol—Asthenia—Cisplatin—testicular cancer	0.00065	0.00129	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—testicular cancer	0.00065	0.00129	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—testicular cancer	0.000647	0.00128	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—testicular cancer	0.000644	0.00128	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—testicular cancer	0.000635	0.00126	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—testicular cancer	0.000631	0.00125	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—testicular cancer	0.000631	0.00125	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—testicular cancer	0.00063	0.00125	CcSEcCtD
Acebutolol—Chills—Methotrexate—testicular cancer	0.000628	0.00124	CcSEcCtD
Acebutolol—Nausea—Ifosfamide—testicular cancer	0.000625	0.00124	CcSEcCtD
Acebutolol—Diarrhoea—Cisplatin—testicular cancer	0.00062	0.00123	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—testicular cancer	0.000619	0.00123	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—testicular cancer	0.000617	0.00122	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—testicular cancer	0.000611	0.00121	CcSEcCtD
Acebutolol—Flushing—Epirubicin—testicular cancer	0.000608	0.0012	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—testicular cancer	0.000608	0.0012	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—testicular cancer	0.000603	0.00119	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—testicular cancer	0.000602	0.00119	CcSEcCtD
Acebutolol—Asthenia—Etoposide—testicular cancer	0.000596	0.00118	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000596	0.00118	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—testicular cancer	0.000594	0.00118	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—testicular cancer	0.00059	0.00117	CcSEcCtD
Acebutolol—Back pain—Methotrexate—testicular cancer	0.00059	0.00117	CcSEcCtD
Acebutolol—Chills—Epirubicin—testicular cancer	0.000588	0.00116	CcSEcCtD
Acebutolol—Pruritus—Etoposide—testicular cancer	0.000588	0.00116	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—testicular cancer	0.000584	0.00116	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—testicular cancer	0.000579	0.00115	CcSEcCtD
Acebutolol—Vomiting—Cisplatin—testicular cancer	0.000576	0.00114	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—testicular cancer	0.000574	0.00114	CcSEcCtD
Acebutolol—Rash—Cisplatin—testicular cancer	0.000572	0.00113	CcSEcCtD
Acebutolol—Dermatitis—Cisplatin—testicular cancer	0.000571	0.00113	CcSEcCtD
Acebutolol—Diarrhoea—Etoposide—testicular cancer	0.000568	0.00113	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—testicular cancer	0.000565	0.00112	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—testicular cancer	0.000565	0.00112	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—testicular cancer	0.000563	0.00111	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—testicular cancer	0.000562	0.00111	CcSEcCtD
Acebutolol—Back pain—Epirubicin—testicular cancer	0.000552	0.00109	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—testicular cancer	0.00055	0.00109	CcSEcCtD
Acebutolol—Malaise—Methotrexate—testicular cancer	0.00055	0.00109	CcSEcCtD
Acebutolol—Dizziness—Etoposide—testicular cancer	0.000549	0.00109	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—testicular cancer	0.000548	0.00108	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000546	0.00108	CcSEcCtD
Acebutolol—Chills—Doxorubicin—testicular cancer	0.000544	0.00108	CcSEcCtD
Acebutolol—Nausea—Cisplatin—testicular cancer	0.000538	0.00107	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—testicular cancer	0.000538	0.00106	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—testicular cancer	0.000536	0.00106	CcSEcCtD
Acebutolol—Cough—Methotrexate—testicular cancer	0.000532	0.00105	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—testicular cancer	0.000529	0.00105	CcSEcCtD
Acebutolol—Vomiting—Etoposide—testicular cancer	0.000528	0.00105	CcSEcCtD
Acebutolol—Rash—Etoposide—testicular cancer	0.000524	0.00104	CcSEcCtD
Acebutolol—Dermatitis—Etoposide—testicular cancer	0.000523	0.00104	CcSEcCtD
Acebutolol—Headache—Etoposide—testicular cancer	0.00052	0.00103	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—testicular cancer	0.00052	0.00103	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—testicular cancer	0.000519	0.00103	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—testicular cancer	0.000519	0.00103	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—testicular cancer	0.000519	0.00103	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000515	0.00102	CcSEcCtD
Acebutolol—Malaise—Epirubicin—testicular cancer	0.000514	0.00102	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—testicular cancer	0.000513	0.00102	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—testicular cancer	0.000512	0.00101	CcSEcCtD
Acebutolol—Syncope—Epirubicin—testicular cancer	0.000511	0.00101	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—testicular cancer	0.00051	0.00101	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—testicular cancer	0.000504	0.000998	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—testicular cancer	0.000502	0.000993	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—testicular cancer	0.000501	0.000993	CcSEcCtD
Acebutolol—Cough—Epirubicin—testicular cancer	0.000498	0.000986	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—testicular cancer	0.000497	0.000985	CcSEcCtD
Acebutolol—Nausea—Etoposide—testicular cancer	0.000493	0.000977	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—testicular cancer	0.00049	0.00097	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—testicular cancer	0.000488	0.000966	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—testicular cancer	0.000486	0.000962	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—testicular cancer	0.000486	0.000962	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—testicular cancer	0.000486	0.000962	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—testicular cancer	0.000484	0.000958	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—testicular cancer	0.000483	0.000957	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000482	0.000955	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—testicular cancer	0.000481	0.000952	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—testicular cancer	0.00048	0.00095	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—testicular cancer	0.000476	0.000943	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—testicular cancer	0.000474	0.000939	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—testicular cancer	0.000474	0.000939	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—testicular cancer	0.000473	0.000937	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—testicular cancer	0.000469	0.00093	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—testicular cancer	0.000466	0.000924	CcSEcCtD
Acebutolol—Oedema—Epirubicin—testicular cancer	0.000465	0.000922	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—testicular cancer	0.000465	0.00092	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—testicular cancer	0.000464	0.000919	CcSEcCtD
Acebutolol—Cough—Doxorubicin—testicular cancer	0.000461	0.000912	CcSEcCtD
Acebutolol—Shock—Epirubicin—testicular cancer	0.000458	0.000907	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—testicular cancer	0.000456	0.000904	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000453	0.000897	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—testicular cancer	0.000452	0.000895	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—testicular cancer	0.00045	0.000891	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—testicular cancer	0.00045	0.000891	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—testicular cancer	0.000449	0.00089	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—testicular cancer	0.000449	0.00089	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—testicular cancer	0.000449	0.00089	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—testicular cancer	0.000448	0.000887	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—testicular cancer	0.000447	0.000885	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000446	0.000884	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—testicular cancer	0.000444	0.000879	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—testicular cancer	0.000444	0.000879	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—testicular cancer	0.000443	0.000878	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—testicular cancer	0.000442	0.000876	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—testicular cancer	0.000438	0.000867	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—testicular cancer	0.000435	0.000861	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—testicular cancer	0.000434	0.00086	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—testicular cancer	0.000432	0.000856	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—testicular cancer	0.000431	0.000853	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000429	0.00085	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—testicular cancer	0.000429	0.000849	CcSEcCtD
Acebutolol—Pain—Methotrexate—testicular cancer	0.000425	0.000842	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000424	0.00084	CcSEcCtD
Acebutolol—Shock—Doxorubicin—testicular cancer	0.000424	0.000839	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—testicular cancer	0.000422	0.000837	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—testicular cancer	0.000421	0.000834	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—testicular cancer	0.000418	0.000829	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—testicular cancer	0.000418	0.000828	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000416	0.000825	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—testicular cancer	0.000415	0.000822	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—testicular cancer	0.000414	0.00082	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—testicular cancer	0.000411	0.000813	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—testicular cancer	0.00041	0.000812	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—testicular cancer	0.00041	0.000811	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000407	0.000806	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—testicular cancer	0.000405	0.000801	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—testicular cancer	0.000402	0.000797	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000402	0.000796	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—testicular cancer	0.000401	0.000795	CcSEcCtD
Acebutolol—Constipation—Epirubicin—testicular cancer	0.000398	0.000788	CcSEcCtD
Acebutolol—Pain—Epirubicin—testicular cancer	0.000398	0.000788	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—testicular cancer	0.000395	0.000783	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—testicular cancer	0.000393	0.000779	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—testicular cancer	0.000393	0.000779	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000392	0.000777	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—testicular cancer	0.00039	0.000771	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—testicular cancer	0.000387	0.000766	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—testicular cancer	0.000384	0.00076	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—testicular cancer	0.000384	0.00076	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—testicular cancer	0.000383	0.000758	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000381	0.000754	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—testicular cancer	0.000379	0.000751	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—testicular cancer	0.000374	0.000741	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000372	0.000736	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—testicular cancer	0.000371	0.000735	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—testicular cancer	0.00037	0.000732	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—testicular cancer	0.000368	0.000729	CcSEcCtD
Acebutolol—Pain—Doxorubicin—testicular cancer	0.000368	0.000729	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—testicular cancer	0.000368	0.000729	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—testicular cancer	0.000368	0.000729	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—testicular cancer	0.000357	0.000707	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—testicular cancer	0.000355	0.000703	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000352	0.000698	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—testicular cancer	0.000352	0.000697	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—testicular cancer	0.000342	0.000678	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—testicular cancer	0.00034	0.000674	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—testicular cancer	0.00034	0.000674	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—testicular cancer	0.00034	0.000674	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—testicular cancer	0.000334	0.000661	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—testicular cancer	0.000329	0.000652	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—testicular cancer	0.000329	0.000651	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—testicular cancer	0.000318	0.000631	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—testicular cancer	0.000316	0.000626	CcSEcCtD
Acebutolol—Rash—Methotrexate—testicular cancer	0.000314	0.000621	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—testicular cancer	0.000313	0.000621	CcSEcCtD
Acebutolol—Headache—Methotrexate—testicular cancer	0.000312	0.000617	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—testicular cancer	0.000309	0.000612	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—testicular cancer	0.000308	0.00061	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—testicular cancer	0.000305	0.000603	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—testicular cancer	0.000296	0.000586	CcSEcCtD
Acebutolol—Nausea—Methotrexate—testicular cancer	0.000295	0.000585	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—testicular cancer	0.000295	0.000584	CcSEcCtD
Acebutolol—Rash—Epirubicin—testicular cancer	0.000293	0.000581	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—testicular cancer	0.000293	0.000581	CcSEcCtD
Acebutolol—Headache—Epirubicin—testicular cancer	0.000292	0.000578	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—testicular cancer	0.000285	0.000564	CcSEcCtD
Acebutolol—Nausea—Epirubicin—testicular cancer	0.000276	0.000548	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—testicular cancer	0.000274	0.000542	CcSEcCtD
Acebutolol—Rash—Doxorubicin—testicular cancer	0.000272	0.000538	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—testicular cancer	0.000271	0.000537	CcSEcCtD
Acebutolol—Headache—Doxorubicin—testicular cancer	0.00027	0.000534	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—testicular cancer	0.000256	0.000507	CcSEcCtD
